Exercise & Training

Feasibility and safety of an exercise-based prehabilitation intervention before cancer surgery: a pilot randomised controlled trial.

TL;DR

Among participants who commenced prehabilitation, attendance, adherence, and completeness were 91.3%, 82.6%, and 85.7% with no serious adverse events, but exploratory clinical outcome estimates were imprecise and recruitment limitations and the small heterogeneous sample preclude broader conclusions regarding feasibility.

Key Findings

Recruitment was limited: 23 of 47 potentially eligible patients screened were recruited, randomised, and completed baseline assessments.

  • Single-centre pilot RCT in a large regional healthcare service with 1:1 randomisation to prehabilitation or usual care.
  • Patients had breast, prostate, or colorectal cancer scheduled for surgery.
  • The authors note that recruitment limitations and the small heterogeneous sample preclude broader conclusions regarding feasibility.

Among participants who commenced prehabilitation, attendance, adherence, and completeness rates were high.

  • Attendance, adherence, completeness, and attrition rates were 91.3%, 82.6%, 85.7%, and 13%, respectively.
  • Participants attended an average of 5.25 ± 2.16 prehabilitation sessions.
  • The intervention was supervised aerobic exercise training 2–3 days per week before surgery.

Twenty participants completed the pre-surgery (T1) and post-surgery (T2) assessments.

  • Prehabilitation n = 11 and usual care n = 9 completed the assessments.
  • Attrition was 13% from the 23 randomised participants.

No serious adverse events occurred; five grade 1 adverse events were recorded in the prehabilitation group.

  • Adverse events were fatigue (n = 3) and muscular pain in the extremities (n = 2).
  • All events were grade 1.
  • Safety was evaluated through adverse event monitoring.

No significant group-by-time interactions were found for cardiorespiratory fitness, health-related quality of life, or fatigue.

  • Exploratory analyses examined changes from baseline to pre-surgery and post-surgery timepoints.
  • 30-day post-operative outcomes (complications and length of stay) were also collected.
  • Estimates were imprecise and did not support firm conclusions regarding intervention effectiveness.

The authors conclude that the small heterogeneous sample and recruitment limitations restrict conclusions about feasibility and effectiveness.

  • Exploratory clinical outcome estimates were imprecise.
  • Findings are from a single centre with breast, colorectal, and prostate cancer patients combined.

What This Means

This small pilot study tested whether a supervised exercise program before cancer surgery was practical and safe for people with breast, prostate, or colorectal cancer. Twenty-three patients were randomly assigned either to exercise sessions 2–3 days per week while waiting for surgery or to usual care. Twenty completed all assessments. Among those who started the exercise program, attendance, adherence, and completion of assessments were high (91.3%, 82.6%, and 85.7%). No serious adverse events occurred; the five minor events (fatigue and muscle pain) were all mild, grade 1. However, recruitment was limited, and the sample was small and mixed across cancer types. The study found no significant differences between groups in fitness, quality of life, or fatigue, but it was too small to show whether the program works. This research suggests that supervised pre-surgery exercise may be safe and doable for some patients, but larger studies are needed to determine whether it improves outcomes.

Check Your Own Numbers

Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.

Upload Your Labs

Have a question about this study?

Citation

Hennessy D, Shee A, Rawstorn J, Evans L, Brown S, Wallen M. (2026). Feasibility and safety of an exercise-based prehabilitation intervention before cancer surgery: a pilot randomised controlled trial.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. https://doi.org/10.1007/s00520-026-11356-9